Showing results (1-10 of 16) with videos related to
Sort By:
Pageof 2
Stem Cell Reviews and Reports|April 17, 2020
Key Success Factors for Regenerative Medicine in Acquired Heart DiseasesPhilippe HénonStem Cell Reviews and Reports|October 20, 2023
Transforming Perspectives in Cardiac Cell Therapy: Hypothesis and Commentary Following Updated Results of a Pilot Study Investigating Very Long-Term Clinical Outcomes in Severe AMI Patients Following Trans-Epicardial Injection of Peripheral Blood CD34+ CellsPhilippe Hénon, Nicolas Bischoff, Robert DallemandStem Cells International|December 4, 2015
Human Very Small Embryonic-Like Stem Cells Are Present in Normal Peripheral Blood of Young, Middle-Aged, and Aged SubjectsHanna Sovalat, Maurice Scrofani, Antoinette Eidenschenk, et al.British Journal of Haematology|February 13, 2003
Cell surface CD43 determination improves diagnostic precision in late B-cell diseasesGeorges Jung, Jean-Claude Eisenmann, Sylvie Thiébault, et al.Biology|April 30, 2021
Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem CellsRachid Lahlil, Maurice Scrofani, Anne Aries, et al.Cytometry. Part a : the Journal of the International Society for Analytical Cytology|December 7, 2007
Three-dimensional distribution patterns of CD34 antigen on nonactivated cord blood cellsGeorges Jung, Eckart Wunder, Alain Dieterlen, et al.International Journal of Molecular Sciences|June 10, 2023
Deciphering the Cardiovascular Potential of Human CD34+ Stem CellsAnne Aries, Céline Zanetti, Philippe Hénon, et al.Stem Cell Reviews and Reports|April 14, 2022
Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and SafePhilippe Hénon, Marc Kowalczyk, Anne Aries, et al.Stem Cell Reviews and Reports|May 9, 2018
VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo ExpansionRachid Lahlil, Maurice Scrofani, Romain Barbet, et al.Experimental Hematology|January 18, 2011
Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cellsHanna Sovalat, Maurice Scrofani, Antoinette Eidenschenk, et al.Pageof 2